Navigation Links
Experimental graft-vs.-host disease treatment equivalent to standard care in Phase 3 trial
Date:12/10/2012

An experimental drug combination for preventing graft-versus-host disease (GVHD) was not significantly better than the standard regimen on key endpoints, according to a report of a phase 3 trial at the American Society of Hematology annual meeting.

The combination of two immunosuppressive compounds -- tacrolimus plus sirolimus -- did not provide a statistically significant, GVHD-free survival benefit over the long-used standard of care, tacrolimus plus methotrexate, said researchers from Dana-Farber Cancer Institute who led the multi-center trial.

However, there were some "upsides" of the tacrolimus/sirolimus treatment that could prove advantageous for certain patients, said Corey Cutler, MD, MPH, first author of the report. Among them: patients engrafted slightly more rapidly and suffered much less from mucositis, a common and painful side-effect that causes sores in the mouth and throat.

But there were also "downsides," Cutler said an increased incidence of veno-occlusive disease (blood clots in the liver) and a slight increase in the rate of late-onset GVHD.

"We were a little disappointed in the results, but excited to offer an alternative to the standard of care for the past 25 years," said Cutler, who, along with Joseph Antin, MD, of Dana-Farber, senior author of the report, had led clinical studies of sirolimus beginning in 2000 in hopes that it would promote better survival from GVHD than the standard treatment.

The phase 3 randomized controlled trial was carried out by the Bone and Marrow Clinical Trials Network (BMT CTN) at 26 centers. It enrolled over 300 patients, the majority of whom had acute leukemia in remission. The patients had received stem cell transplants from a matched sibling donor.

The primary endpoint of 114-day acute GVHD-free survival was 67 percent in the tacrolimus/sirolimus group and 62 percent in the tacrolimus/methotrexate group a difference that was not statistically significant
'/>"/>

Contact: Teresa Herbert
teresa_herbert@dfci.harvard.edu
617-632-4090
Dana-Farber Cancer Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Experimental Chemo Combo for Colon Cancer Disappoints
2. Experimental Pill for Multiple Sclerosis Shows Promise
3. Experimental Gel May Help Those With Advanced Parkinsons
4. Experimental Drug Eases Autistic Behaviors in Mice
5. Experimental Drug Helps Fight Some Childhood Cancers, Study Finds
6. Experimental drug improves muscle strength among male cancer patients
7. Experimental Vaccine Seems to Stop Nicotine Addiction in Mice
8. Content Writing King Announces Cancellation Of Experimental Video Creation Process For Their Article Marketing Website
9. Fertility preservation with cryopreservation of ovarian tissue: from experimental to mainstream
10. Experimental drug may extend therapeutic window for stroke
11. Experimental Chemical Helps Blind Mice See
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Diego, CA (PRWEB) August 28, 2014 Vitals, ... has named Dr. Sabrina Fabi of Cosmetic Laser Dermatology one ... allows hundreds of thousands of patients to share their doctor ... including bedside manner, face time, and follow-ups. The Vitals Top ... in California, Dr. Fabi was ranked one of the highest ...
(Date:8/28/2014)... 28, 2014 Maryland Laser Skin and ... level Allergan Privilege Program status from Allergan, the ... Botox, Juvederm, and Voluma. Maryland Laser Skin and Vein ... of these treatments. The dermatologists at Maryland Laser Skin ... are one of the leading practices in this specialty. ...
(Date:8/28/2014)... Pass, OR (PRWEB) August 28, 2014 Women ... according to two leading global authorities on the subject of ... and Kathy Kelly of the Women for Water Partnership and ... must be at the table. Kathy Kelly was interviewed by ... show of August 25, 2014. , Kathy Kelly became ...
(Date:8/28/2014)... Laguna Hlils, CA (PRWEB) August 28, 2014 ... enterprise document management and workflow solutions, announced today ... Success” Award by the SoCal Chapter of the ... of Bond Consulting Services. IAMCP was founded in ... reaches Microsoft programs and the IT community at ...
(Date:8/28/2014)... 28, 2014 It is not uncommon for ... unsuccessful dieting attempts. Many face ridicule and judgment and find ... thoughts and feelings, wondering why they keep gaining weight and ... solace in comfort foods, eating more and gaining more, leaving ... , Diet Doc has helped thousands safely, successfully and ...
Breaking Medicine News(10 mins):Health News:Dr. Sabrina Fabi of Cosmetic Laser Dermatology Recognized as Vitals Top 10 Doctor 2Health News:Maryland Laser Skin and Vein Receives Diamond Status From Allergan 2Health News:Women for Water Partnership and Sharon Kleyne Call for Greater Women’s Role in Global Water Issues 2Health News:Women for Water Partnership and Sharon Kleyne Call for Greater Women’s Role in Global Water Issues 3Health News:Altec and Bond Consulting Services Receive Award from the International Association of Microsoft Channel Partners SoCal Chapter 2Health News:Altec and Bond Consulting Services Receive Award from the International Association of Microsoft Channel Partners SoCal Chapter 3Health News:Diet Doc’s Medical Weight Loss Programs Announce New Help for Patients Who Want to Overcome Depression Caused by Excess Weight 2Health News:Diet Doc’s Medical Weight Loss Programs Announce New Help for Patients Who Want to Overcome Depression Caused by Excess Weight 3
... Denise Mann HealthDay Reporter , WEDNESDAY, May 2 (HealthDay ... H5N1 avian (bird) flu virus can morph -- with the possibility ... global pandemic -- may help nations prepare for the impending threat. ... publishing the study in the May 2 online issue of ...
... combination of two inhibitors of protein mTOR stops the growth ... a study by researchers of the Group of Metabolism and ... are been published on the online edition of the journal ... hepatocellular carcinoma is the fifth most common cancer and, due ...
... NJ. May 2, 2012. Kessler Foundation will be represented by ... in Multiple Sclerosis to be held at the Congress Center ... DeLuca, PhD, the Foundation,s VP of Research and Training will ... and James Sumowski, PhD. Kessler Foundation is known ...
... , WEDNESDAY, May 2 (HealthDay News) -- Chemistry in ... levels, a new, small study says. Along with ... study could prove important in finding ways to treat ... illness linked with decreased motivation, Vanderbilt University researchers said. ...
... CT is nearly four times better than radiographic skeletal survey, ... extent of disease in patients with multiple myeloma, a new ... Maryland in Baltimore, included 51 patients who had both a ... body CT examination. The total number of lesions detected ...
... discovered that a protein that transports sodium, potassium and chloride ... deadliest type of brain cancer, moves and invades nearby healthy ... open-access journal PLoS Biology , also suggest that a ... of glioblastoma cells. "The biggest challenge in brain cancer ...
Cached Medicine News:Health News:Once-Banned Bird Flu Study Suggests Pandemic Threat Is Real 2Health News:Once-Banned Bird Flu Study Suggests Pandemic Threat Is Real 3Health News:Combination of 2 drugs reverses liver tumors 2Health News:Clues to 'Slacker' Behavior Found in Brain, Study Says 2Health News:Low-dose whole-body CT finds disease missed on standard imaging for patients with multiple myeloma 2Health News:Research yields new clues to how brain cancer cells migrate and invade 2
(Date:8/27/2014)... -- By now, if you haven,t heard about the ALS ... The awareness campaign has brought this devastating disease to the ... $88.5 Million (and counting) for ALS. Every day, more and ... to as well. One such company, Acorn Stairlifts ... actually works with ALS sufferers and helps to provide solutions ...
(Date:8/27/2014)... Holdings, Inc. (NYSE: HRC ) invites you ... Stanley Global Healthcare Conference on September 8, 2014, at ... listen to the live discussion via the internet link ... http://cc.talkpoint.com/morg007/090814a_ac/?entity=26_7CLOGQP .  A recorded replay of the discussion ... live event and accessible at the links above until ...
(Date:8/27/2014)... -- North American lighting leader OSRAM SYLVANIA has ... new OSRAM ITOS ® PHASER ® 3000, the ... endoscopy and surgical head lamps that delivers the same brightness ... life. "We,re honored to be recognized by ... technologies of the past year," said Andreas Osten , ...
Breaking Medicine Technology:Acorn Stairlifts Gives a Lift to the ALS Ice Bucket Challenge 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3
... , , REDWOOD CITY, Calif. , ... separate collaborations in pharmaceutical manufacturing with Dishman Pharmaceuticals and ... of American Pacific Corporation. These agreements expand the application ... innovator pharmaceutical products. , Under the new agreements, ...
... , Rowinsky to Serve on RRD International,s ... Feb. 17 RRD International, a strategy-driven ... Eric Rowinsky , M.D. will oversee oncology product ... Advisory Board.  Dr. Rowinsky is a highly accomplished cancer ...
Cached Medicine Technology:Codexis Expands Pharmaceutical Manufacturing Partnerships 2Codexis Expands Pharmaceutical Manufacturing Partnerships 3Cancer Expert Dr. Eric Rowinsky to Oversee Oncology Product Development at RRD International 2Cancer Expert Dr. Eric Rowinsky to Oversee Oncology Product Development at RRD International 3
... Intramedullary fixation has greatly ... tibial fractures. The Biomet Low ... indicated in the treatment of ... metastatic disease with pathologic or ...
Arthroscopic instrument system for instability and SLAP fixation....
The Charlotte Shoulder™ System address arthroscopic, mini-open and open procedures with time saving instrumentation....
Arthroscopic instrument system for instability and SLAP fixation....
Medicine Products: